A Role for the Amygdala in Impairments of Affective Behaviors Following Mild Traumatic Brain Injury

Introduction

Traumatic brain injury (TBI) is a serious public health concern that affects over 1.5 million people each year and results in the death and disability of thousands, with mild TBI comprising the greatest proportion of these cases (Kay et al., 1993; Coronado et al., 2011; McMahon et al., 2014). In the civilian population, mild TBI occurs largely because of playing contact sports such as American football, soccer, and ice hockey, whereas military personnel are exposed to mild blast TBI (Prins et al., 2013; Baldwin et al., 2018). Although sports-related concussions and mild blast TBI occur through different means, they share a similar prevalence of about 15–20% in civilian and veteran populations, as well as similar behavioral deficits (McKee and Robinson, 2014; Gardner and Yaffe, 2016).

Depression, anxiety, and fear/post-traumatic stress disorder (PTSD) are affective behavioral impairments that are among the most frequently reported behavioral problems that manifest in the chronic period following mild TBI (Baldassarre et al., 2015; Ellis et al., 2015; Horn et al., 2016; Bunt et al., 2020). The severity of these deficits is known to vary by sex, in that women are more prone to exhibiting affective disorders post-injury (Broshek et al., 2005; Bunt et al., 2020). Interestingly, the heightened response women exhibit following mild TBI is not consistently seen following moderate or severe TBI (Lavoie et al., 2017). Clinical studies used qualitative methods to diagnose the emotional state of an individual in conjunction with brain imaging tasks allowing for the identification of potential brain regions involved in affective disorders (Lange et al., 2016; Chong and Schwedt, 2018; Bunt et al., 2020; Teymoori et al., 2020). In preclinical models, validated behavioral assays have become the mode of quantifying what are usually thought to be subjective, affective states (Can et al., 2011, 2012; Calhoon and Tye, 2015; Eagle et al., 2016; Liu et al., 2018). Through these assays and the accompanied use of other biological techniques, mechanistic underpinnings of each disorder have been identified, as well as sex differences in deficit expression. However, limitations in the effectiveness of current drug regimens for affective disorders suggest that deficits following mild TBI should be examined in a new light (Xiong et al., 2013). Neurobiological studies have suggested that the amygdala is a key brain region involved in emotional processing (Phelps and Ledoux, 2005; Pessoa, 2010; Kim et al., 2011; Korgaonkar et al., 2019), and its impairment is associated with the manifestation of the affective disorders seen after TBI (Han et al., 2015; Hoffman et al., 2019). Understanding the mechanistic underpinnings of dysfunction in this brain region following injury will advance the field of TBI research. This review will discuss the current methods, corresponding mechanisms, and drug therapies used to identify and treat affective behavioral deficits in human and animal models of mild TBI. Because of the high comorbidity and mechanistic similarities across depression, anxiety, and fear, we suggest that they should be considered as a collective deficit in emotional processing stemming from impairment within the amygdala.

Human Studies

Definition and Epidemiology of Mild TBI

Mild TBI is often used interchangeably with concussion (Sussman et al., 2018) and affects approximately 15–20% of the population (McKee and Robinson, 2014; Gardner and Yaffe, 2016). Further, about 50% of people fail to report their injury suggesting that a majority of mild TBI incidents may be repetitive (Vargas et al., 2015; Pryor et al., 2016; Baldwin et al., 2018). Typically, mild TBI is defined by a Glasgow Coma Scale score between 13 and 15 along with a lack of, or very minimal, impairment in the level of consciousness. The two main types of mild TBI are contact-based such as sports-related concussions where some form of physical contact occurs, and blast-based which usually occurs as a result of exposure to an explosion (blast wave) during combat (Prins et al., 2013; Baldwin et al., 2018). Moreover, although it can happen at any age, mild TBI is particularly prevalent amongst adolescents who participate in contact sports (Baldwin et al., 2018), and young adults, who represent most enlisted military personnel (Lange et al., 2016). The risk for mild TBI is greater in boys and men due to sports including football and ice hockey and the fact that the military is a male-dominant field. However, girls are more prone to concussion when looking at gender-comparable sports (Baldwin et al., 2018).

Behavioral Consequences of Mild TBI

Immediately after a concussion, patients experience headache, dizziness, nausea, sensitivity to noise, motor impairments, and deficits in executive functioning (Szczupak et al., 2016). Typically, these somatic signs and symptoms are documented using either the Sport Concussion Assessment Tool (SCAT) or the Immediate Post-concussion Assessment of Cognitive Testing (ImPACT). These acute symptoms resolve within 7-10 days in a vast majority of patients but can exist for 90 days or more in those that are then diagnosed with post-concussion syndrome (Ryan and Warden, 2003). In addition, and to a greater extent in those that have suffered multiple concussions, brain-injured patients can develop deficits in learning and memory and affective behavior disorders such as depression, anxiety and fear which can persist for years post-injury (Manley et al., 2017). Military personnel who suffer from mild blast TBI experience similar acute symptoms as individuals suffering from sports-related concussion and develop chronic problems such as impaired cognition (Waid-Ebbs et al., 2014), depression and post-traumatic stress disorder, which largely consists of anxiety and fear-related behaviors (Shively and Perl, 2012). In the chronic post-concussion phase, both cognitive and affective behaviors are assessed using more specific and sensitive measures such as the Wechsler Intelligence Scale, the Tower of London test, the Patient Health Questionnaire (PHQ), the Generalized Anxiety Disorder-7 (GAD-7) scale and the Clinician Assessment of PTSD each with its defined threshold for determining the severity of the deficit (Tables 1, 2). Although previous research has found that both sexes exhibit some degree of affective impairment, the consensus of literature states that women experience significantly exacerbated symptoms (Broshek et al., 2005; Sufrinko et al., 2017). Thus, the prevalence of depression, anxiety, and fear is increased in women compared to men (Bunt et al., 2020). Moreover, studies suggest that the severity of behavioral deficits in women depends on their menstrual phase (Bazarian et al., 2010; Stein, 2013; Wunderle et al., 2014). For example, women injured when their progesterone concentrations were high had lower health scores 1-month following injury (Wunderle et al., 2014). Another study showed that menstrual phase had no effect on concussion symptom severity (Mihalik et al., 2009); however, this study was conducted using healthy collegiate athletes. Combined, these limited and conflicting studies highlight the need for further investigation into the impact menstrual cycle has on behavioral consequences of mild TBI in women. Moreover, men also show a degree of affective impairment as well as significant cognitive deficits post-injury (Roberts et al., 2019). Since affective behavioral disorders have cognitive components to them, this can serve as a way through which men exhibit greater signs of psychological impairment.

Table 1. Clinical studies that evaluated cognition (such as executive function, memory, and concentration) and emotional (such as anxiety, depression, and PTSD) behaviors following mild TBI.

Table 2. Clinical studies that evaluated structural/functional alterations (using imaging techniques) in patients that were tested for cognitive (such as executive function, memory, and concentration) and emotional (such as anxiety, depression, and PTSD) behaviors following mild TBI.

A search of clinical studies in PubMed using search terms such as mild TBI and cognition or mild TBI and depression or anxiety or fear revealed almost twice as many publications focused on cognitive impairments after mild TBI. However, recent studies revealed that patients develop depression, anxiety, and fear years after injury, which greatly contributed to a decreased quality of life (Baldassarre et al., 2015; Giguère et al., 2019; Tables 1, 2). Affective disorders are reported in approximately 20% of brain-injured individuals (Schwenk et al., 2007; McKee and Robinson, 2014; Scholten et al., 2016; Brassil and Salvatore, 2018), and can impact other behavioral outputs. For example, depression increases the bias to aversive memory recall (Leal et al., 2017), anxiety decreases the ability to handle stress as it directly involves the hypothalamic-pituitary-adrenal (HPA) axis (Maeng and Milad, 2015), and the expression of fear is linked to aggression (Gao et al., 2014).

Post-traumatic depression is characterized by alterations in affect, diminished interest in pleasurable activities, negative and intrusive thoughts, reductions in physical movement, decreased executive functioning, and loss of energy (Lavoie et al., 2017). Depression is evaluated based on the results from the Beck Depression Inventory II, the PHQ-9, or the Structured Clinical Interview for DSM-IV/V Axis 1 Disorders (criteria are described in Tables 1, 2). Approximately 15% of individuals with mild TBI and mild blast TBI suffer from post-injury depression (Schwenk et al., 2007; McKee and Robinson, 2014). This is a gross underestimation because more than 50% of individuals with a mild TBI fail to report symptoms (Rao et al., 2010; Vargas et al., 2015; Pryor et al., 2016). About 21% of individuals with mild TBI experience some form of anxiety disorder within the first year of injury which increases to 36% after the first year due to high long-term prevalence (Scholten et al., 2016); anxiety was measured using the Beck Anxiety Inventory, the GAD-7 scale or the PHQ (criteria are described in Tables 1, 2). The manifestation of fear-related behaviors (“avoiding similar situations”) is a hallmark of PTSD which also includes difficulty sleeping and flashbacks (Brewin et al., 2017). In the civilian population, PTSD occurs at a prevalence rate of less than 25%, whereas over 35% of military personnel exposed to mild blast TBI exhibit symptoms of PTSD (Schneiderman et al., 2008; Shu et al., 2014; Brassil and Salvatore, 2018). Individuals exposed to mild blast TBI experience heightened stress responses and emotional memory associations due to the nature of their situation. In addition, repeated traumatic events occurring during deployment results in strong, conditioned fear learning and expression of fear which may be the basis for the high risk of PTSD in this group (Glenn et al., 2017). Tests used to detect PTSD and their criteria are described in Tables 1 and 2.

Depression, anxiety, and fear-related behaviors following mild TBI are comorbid conditions (Tables 1, 2; Jorge et al., 2004; Ellis et al., 2015; Mohammad Farris Iman Leong Bin Abdullah et al., 2018; Teymoori et al., 2020). A study of over 100 individuals with a mild TBI used a Structured Clinical Interview for DSM-IV axis I disorders to determine that 25% showed signs of depression and 14% had anxiety, with fear-evoked PTSD representing a major contributor to this anxiety. Importantly, about half of these individuals had comorbid anxiety and depression (Mohammad Farris Iman Leong Bin Abdullah et al., 2018). In another study, the same structured interview was utilized, as well as the Hamilton Depression and Anxiety Scales to show that 33% of mild TBI patients exhibited symptoms of depression within the first year and within this group, 76% also had anxiety (Jorge et al., 2004).

Structural Changes Following Mild TBI

The primary structural pathology of mild TBI is damage to white matter tracts. Post-concussion white matter changes are largely present in the frontal, parietal, and temporal lobes of the brain (Chong and Schwedt, 2018). An advanced MRI study demonstrated significantly altered diffusion properties of white matter tracts in concussed athletes, which were correlated with acute symptoms post-injury and functional deficits. Specifically, an increase in mean diffusivity in the corpus callosum, superior longitudinal fasciculus, and the corona radiata of the concussed group compared to healthy controls has been reported (Mustafi et al., 2018). Structural impairment can persist in adolescents and individuals who suffer multiple concussions, contributing to prolonged behavioral impairment (Chong and Schwedt, 2018). Furthermore, a study investigating former high school athletes that suffered repeated concussions showed higher mean diffusivity in the anterior limb of the internal capsule over 20 years post-injury (Terry et al., 2019).

Functional MRI studies have shown changes in hippocampal connectivity following repeated collisions in collegiate football players (Slobounov et al., 2017; Wojtowicz et al., 2018). A study of professional rugby players with a history of concussion demonstrated no significant differences between cortical thickness, but smaller whole brain hippocampus and left amygdala volumes compared to healthy controls (Wojtowicz et al., 2018). Neuroimaging studies of mild blast TBI patients tend to be understudied; however, one study showed that injury to the hippocampus in veteran populations results in globally decreased gray matter volumes compared to controls (Bhattrai et al., 2019). Alterations in hippocampal connectivity relate directly to cognitive and affective behavior deficits (Belujon and Grace, 2011; Leal et al., 2017). In military personnel who had suffered at least one mild TBI, the radial distance of the amygdala was positively correlated with time since injury, meaning individuals further removed from injury showed greater amygdala thickness (Tate et al., 2016). Moreover, imaging performed on individuals with moderate TBI and depressive symptoms demonstrated that these individuals have increased amygdala connectivity relative to healthy controls, and this increased connectivity was associated with affective disorders (Han et al., 2015). The amygdala is a key hub of emotional processing (Phelps and Ledoux, 2005; Pessoa, 2010; Kim et al., 2011; Korgaonkar et al., 2019), therefore, changes in its size or connectivity can lead to affective behavior impairments seen post-injury (Han et al., 2015; Hoffman et al., 2019). Structural impairments in the hippocampus and amygdala post-injury provide avenues through which affective behavioral disorders can manifest in individuals; however, these structures are not widely investigated in neuroimaging studies following mild TBI. Sex differences in the structural impairments following mild TBI are also understudied and filling this gap in literature would aid in understanding the relationship between behavioral outcome and structural alterations. Most studies that have evaluated chronic behavioral deficits in concussed patients typically do not provide assessment of structural or functional alterations (Table 1). The preponderance of studies that have included imaging correlates for behavioral changes focus on structures that may be more vulnerable to concussions such as white matter tracts and cortical areas at or near the sites of impact (Table 2), making it difficult to determine specific relationships between behaviors and intracerebral alterations.

Animal Studies

Definition and Models of Mild TBI

Multiple animal models of mild TBI that effectively reflect structural changes (axonal injury and neurodegeneration) and impairments in motor, cognitive, and affective behaviors typically reported in brain-injured clinical populations, have been developed (Malkesman et al., 2013; Bodnar et al., 2019). Mild TBI can be induced through impact to the intact skull, head, or exposure to a blast wave. Impact to the intact skull by way of an extended piston tip or a weight drop that does not result in skull fracture or hematoma is defined as “mild” (Ma et al., 2019). Because both sports-related concussions and mild blast TBI are characterized by their repetitive nature, the greatest challenge in developing a clinically appropriate animal model of contact or blast TBI is selecting the best approach and variability across the animal models exists in impact site, frequency, and severity (Weber, 2007). When performing repetitive mild TBI, impact frequency must be translational, realistically modeling the frequency in the human condition. Moreover, despite the immense variability that can exist between models of mild TBI, validation must be based on the structural and behavioral changes of mild TBI seen in human populations. To reduce variability in the site and magnitude of impact, animals are typically restrained and therefore require anesthesia such as isoflurane or ketamine (Rowe et al., 2014). Mild blast TBI has been performed with (Rowe et al., 2014) or without (Uddin et al., 2019) anesthesia, using a shock tube and cranium only blast injury apparatus, respectively (Kuehn et al., 2011; Ma et al., 2019; Uddin et al., 2019). Anesthetized animals exhibit similar behavioral and structural deficits as seen in awake rodent and clinical mild TBI models; therefore, the protective effects of the anesthetics are often minimal, but must be considered when deciding on which preclinical mild TBI model to utilize (Rowe et al., 2014). Moreover, it is important to note that the use of anesthesia limits complete fidelity of animal models to reflect concussion in humans, as humans are not anesthetized during injury.

Behavioral Changes Following Mild TBI

Preclinical models of mild TBI exhibit short-and-long-term behavioral deficits post-injury. Acutely, brain-injured animals show impaired locomotion, working memory, and anxiety (Wright et al., 2017). Repetitive brain injury has been shown to lead to chronic deficits in social behavior, spatial working memory, spatial learning, and other prefrontal cortex and hippocampal-associated functions (Cheng et al., 2014; Nolan et al., 2018). The worsening or development of affective behavioral deficits is frequently reported in preclinical models of single and repetitive TBI (Teutsch et al., 2018; Popovitz et al., 2019; Beitchman et al., 2020), and mild TBI, and include spatial memory impairments, depression, anxiety, and impairments in fear-related behaviors, as seen in clinical populations (Petraglia et al., 2014; Wright et al., 2017). Moreover, animals subjected to repetitive brain injuries are at an increased risk of experiencing prolonged behavioral impairments post-injury (Petraglia et al., 2014). Affective behavioral impairments are also understudied in preclinical models of mild TBI, which often highlight the presence of these disorders without uncovering their mechanistic basis or examining potential therapies. Due to these issues, there are numerous gaps in the field of post-traumatic depression, anxiety, and fear, and these gaps will be explored in upcoming sections of the review.

Male and female brain-injured animals demonstrate impairment in both cognitive and affective behaviors, but male animals typically exhibit exacerbated cognitive impairments and female brain-injured animals show exacerbated affective disorders (Wright et al., 2017). TBI disrupts the female estrous cycle, causing imbalances in estrogen and progesterone levels and makes female animals more vulnerable to the negative effects of stressors (Wright et al., 2017; Fortress et al., 2019). Preclinical data investigating the effects of the estrous cycle on injury-induced behavioral outcomes are more extensive and conclusive than the current clinical data. Despite this knowledge on sex differences in behavioral outcomes, most preclinical models of mild TBI solely utilize male animals. However, although sex differences in structural and behavioral outcome of mild TBI are historically understudied, they have been gaining more attention in recent years.

Pathology

Structural changes observed in animals following mild TBI closely reflect those seen in humans exhibiting minimal damage, mostly present as traumatic axonal injury in white matter tracts (Mierzwa et al., 2015; Kikinis et al., 2017; Hoogenboom et al., 2019). Imaging studies demonstrate decreased mean diffusivity in the genu of the corpus callosum and increased fractional anisotropy in white matter tracts in injured animals one-week post-injury (Kikinis et al., 2017; Hoogenboom et al., 2019) as well as decreased axial diffusivity in the corpus callosum 2 weeks-post repetitive mild TBI (Wright et al., 2017). Diffusion tensor imaging showed decreased expression of myelin basic protein in the corpus callosum and high fractional anisotropy in white matter tracts immediately after injury which are normalized in the months following injury in most cases (Herrera et al., 2017). MRI in a mouse model of repetitive mild TBI demonstrated microgliosis in white matter tracts acutely post-injury (Robinson et al., 2017). Sex differences in pathology following mild TBI are largely understudied. However, one study demonstrated that following single and repetitive mild TBI, male animals showed increased astrocyte reactivity in the corpus callosum only after mild TBI, whereas female animals showed increased reactivity only following repetitive mild TBI (Wright et al., 2017). The results of this study would suggest that potential sex differences in pathology should be further investigated.

Preclinical studies have also investigated structural deficits in regions such as the hippocampus and amygdala (Table 3). Single and repetitive closed head injury in young adult rats found significant changes in fractional anisotropy in the central amygdala (CeA, Kulkarni et al., 2019). These changes were seen at 7-8 weeks post-injury and were associated with impairments in affective behavior regulation. This study also demonstrated that repetitive mild TBI showed greater amygdala alterations than single injury; however, both injury models exhibited impairments compared to controls (Kulkarni et al., 2019). Moderate TBI in adult male rats resulted in dendritic hypertrophy in the basolateral (BLA) amygdala at 7- and 28-days post-injury, demonstrating the long-term structural alterations of the amygdala (Hoffman et al., 2017). Increased dendritic spine density in the amygdala, as well as increased dendritic branching in dendrites further from the soma regions have been found in a mouse model of mild blast TBI. This may be indicative of increased communication within amygdala circuitry following blast injury (Ratliff et al., 2019). Repeated mild blast TBI has shown alterations in the transcriptome within the BLA and CeA subregions which were associated with anxiety-like behaviors (Blaze et al., 2020), and single blast injury has led to a decrease in the number of BLA pyramidal neurons (Heldt et al., 2014). An impairment in inhibitory transmission in the BLA following mild TBI as indicated by a decrease in GABAergic neurons has also been reported (Almeida-Suhett et al., 2014) as well as decreased network excitability in the amygdala (Palmer et al., 2016). Repeated mild TBI was associated with decreased microglia in the hippocampus and BLA of brain-injured animals (Cheng et al., 2019) and hypoconnectivity in the hippocampus (Kulkarni et al., 2019). These studies highlight the need to further investigate both circuit-based dysfunction (e.g., alterations in the excitatory/inhibitory balance) and cellular alterations (neuronal damage, glial activation) within the various regions of the amygdala.

Table 3. Structural (using histology and/or imaging) and behavioral (cognition, anxiety, depression, fear) alterations in animal models of mild TBI.

Current Treatment Strategies for Post-Traumatic Affective Disorders

Human Studies

Current treatment strategies for depression, anxiety and fear/PTSD in brain-injured patients utilize best practices that are in place for treating these disorders in patients that have not suffered a TBI (Plantier and Luauté, 2016; Gupta et al., 2019; Silverberg and Panenka, 2019). Thus, serotonin reuptake inhibitors (SSRIs) are the most utilized therapy for post-traumatic depression (Kraus et al., 2017; Silverberg and Panenka, 2019). However, a meta-analysis of clinical trials using SSRIs following concussion found that these drugs have no benefit for post-traumatic depression in some cases, but rather their effects stem from robust placebo effects (Silverberg and Panenka, 2019). Alternate therapeutic strategies include cognitive behavioral therapy (CBT) which helps modify negative thought patterns and has been used extensively in military veterans (Cooper et al., 2015; Fann et al., 2015; Ponsford et al., 2015). In addition to CBT, which is focused on information processing and memory, motivational interviewing has also been used on brain-injured military veterans suffering from PTSD and civilian populations with post-traumatic anxiety (Cooper et al., 2015). Melatonin, which can improve sleep quality following mild TBI, has been effective in attenuating anxiety in brain-injured individuals (Grima et al., 2018). Sedatives such as benzodiazepines are used to treat anxiety in individuals with mild TBI by working as positive allosteric modulators that increase the activity of the GABA-A receptor although the effects of benzodiazepines are transient and variable (Flower and Hellings, 2012; Plantier and Luauté, 2016).

Animal Studies

Therapies for affective disorders that are currently utilized on brain-injured patients have typically not been tested in clinically relevant animal models of TBI (Cryan et al., 2002). Rather, pharmacologic interventions aimed at reducing acute neurodegeneration after TBI use depression, anxiety, and fear behavior as outcome measures. For example, both hyperbaric oxygen therapy and lithium (which inhibits the activity of the apoptosis regulator glycogen synthase kinase-3) have been used in animal models of TBI to reduce depression-like symptoms (Shapira et al., 2007; Lim et al., 2017). Similarly, antagonists of either the glutamate receptor, glucocorticoid receptor, or the corticotropin releasing factor (CRF) receptor 1 ameliorated post-traumatic anxiety-like behaviors (Fox et al., 2016; Kosari-Nasab et al., 2019) or PTSD-like behaviors (Perez-Garcia et al., 2018). Together with the clinical data, the pre-clinical studies highlight the disconnect between the bench and the bedside when it comes to treating affective disorders in TBI patients.

An Integrated Approach to Post-Traumatic Affective Behaviors: The Role of the Amygdala

The Significance of the Amygdala

Human and animal studies of mild TBI have demonstrated that affective behavioral disorders are frequent long-term consequences of injury but have insufficient treatment options. Therefore, this section will highlight the idea that deficits in affective behavior following TBI, and specifically mild TBI, may depend heavily on neuronal projections and neurochemicals originating within the amygdala (Han et al., 2015; Horn et al., 2016; Ratliff et al., 2019; Beitchman et al., 2020). The function, structure, and connectivity of the amygdala is disrupted following TBI suggesting that this region may be a source of behavioral impairment. For example, hyperactivity of the amygdala is suggested to be involved in the manifestation of affective disorders in brain-injured patients (Han et al., 2015). Clinical and preclinical neurobiological studies have supported the idea that the amygdala, a major component of the limbic system, may be a hub for regulating affective behaviors (Phelps and Ledoux, 2005; Etkin et al., 2010; Pessoa, 2010; Calhoon and Tye, 2015; Korgaonkar et al., 2019). The amygdala sends projections to multiple brain regions thereby involving it in the various circuits responsible for the expression of affective behaviors and is also home to a diverse array of neurotransmitters and neuropeptides which boosts its potential to mediate impairments in affective behaviors (Phelps and Ledoux, 2005; Etkin et al., 2010; Pessoa, 2010; Felix-Ortiz and Tye, 2014; Calhoon and Tye, 2015; McGarry and Carter, 2016; Paretkar and Dimitrov, 2018; Korgaonkar et al., 2019).

Anatomic Pathways: The Basolateral and Central Amygdala

The BLA and CeA are the two primary subregions of the amygdala widely known for their involvement in depression and fear and anxiety, respectively. Their projections to various brain regions aid in the regulation of these disorders, in that disruption of these pathways can lead to disorder expression (Kim and Jung, 2006; Calhoon and Tye, 2015; Leal et al., 2017). This section will examine how the manifestation of depression, anxiety, or fear can occur through divergent circuitry arising from the various subregions of the amygdala.

Disruptions in the BLA-derived circuitry drive the expression of both cognitive and emotional aspects of depression-like behaviors. Preclinical studies show that the BLA exhibits neuronal hypertrophy in response to TBI (Hoffman et al., 2017) and increased dendritic branching following mild blast TBI (Ratliff et al., 2019). Animal models of depression exhibit impaired processing through the expression of anhedonia, despair, and prefrontal and hippocampal-dependent cognitive deficits (Paul et al., 2005; Der-Avakian and Markou, 2012). The BLA is also the main input nucleus receiving sensory information from the thalamus which is imbued with emotional value and associations are made between neural stimuli and outcomes of positive or negative valence (Janak and Tye, 2015). Cognitive components of depression are driven by the BLA coordinating emotional learning and memory via projections to the prefrontal cortex and the ventral hippocampus (McGarry and Carter, 2016; Leal et al., 2017). Disruptions in these pathways in humans lead to impaired emotional memory, creating a bias toward negative thoughts (Leal et al., 2017). Activation of BLA neurons following mild TBI in animals potentiates glutamatergic targets leading to excitotoxicity in other brain regions including the hippocampus (Reger et al., 2012). The BLA also projects to the nucleus accumbens shell, where it inhibits dopamine release leading to low motivational states (McGarry and Carter, 2016). A decrease in dopamine release and reuptake in the nucleus accumbens has been reported in the chronic period following TBI in animals (Chen et al., 2017) which may underlie decreased motivation that leads to a depressive phenotype. Moreover, activation of the BLA during REM sleep, which is reduced in brain-injured patients, is critical for sleep-dependent emotional processing (Mcgaugh, 2004; Mantua et al., 2017; Clark et al., 2020). When this processing is impaired, there is an increase in arousal to negative words and experiences seen in patients (Liu et al., 2012). Collectively, these data provide a basis for the BLA, via its connections to the prefrontal cortex, hippocampus, and nucleus accumbens to regulate the expression of post-traumatic depression.

The BLA also aids in recruiting CeA neurons in response to threatening cues (Calhoon and Tye, 2015). Brain imaging studies in rodents found significant alterations in the CeA following single and repetitive mild TBI which corresponded to impairments in affective behavior (Kulkarni et al., 2019). The coordinated activity of the CeA, the bed nucleus of the stria terminalis (BNST), the ventral hippocampus, and the prefrontal cortex is required for the interpretation of stimuli as threatening to produce an anxiety-like response. Threatening cues induce anxiogenic behavior because of increased activation of the CeA and the BNST, whereas hyperexcitation within the CeA promotes arousal and hypervigilance and leads to the association of non-threatening factors with potential danger (Calhoon and Tye, 2015). Information regarding potential threats flows forward from the CeA to the BNST, then to the hippocampus and prefrontal cortex, and back from the prefrontal cortex and the hippocampus to the CeA (Calhoon and Tye, 2015); dysfunction in the hippocampus and the prefrontal cortex also contributes to anxiety-like behaviors (Cominski et al., 2014). Fear and anxiety-provoking circuits share numerous similarities, and contextual fear conditioning requires strong input from the hippocampus to relate contextual cues to an aversive stimulus (Kim and Jung, 2006; Calhoon and Tye, 2015). Moreover, medial septum cholinergic inputs into the hippocampus are needed for appropriate processing of contextual cues as background information (Calhoon and Tye, 2015; Staib et al., 2018). The CeA also projects to the paraventricular nucleus of the hypothalamus (Beaulieu et al., 1986) and hyperactivity in the CeA leads to disruption of the hypothalamic-pituitary-adrenal (HPA) axis and anxiety-like behaviors and alterations in the natural fear response (Flandreau et al., 2012; Calhoon and Tye, 2015). In animals, TBI induces disruption in HPA circuitry resulting in compromised emotional regulation and, specifically, anxiety (Tapp et al., 2019). These data suggest that the CeA may be a likely nucleus mediating post-traumatic anxiety and fear behaviors.

Neurochemical Pathways: γ-Amino Butyric Acid and CRF

Whereas different subregions of the amygdala may be more responsible for the expression of one affective disorder over the other, neurochemical transmission within the amygdala may contribute to the comorbid expression of depression, anxiety, and fear-related behaviors. These neurochemicals consist of the primary excitatory neurotransmitter glutamate, the primary inhibitory neurotransmitter γ-amino butyric acid (GABA), and CRF, the peptide hormone largely known to be involved in the stress response. Alterations in the concentration or activity of these neurochemicals have been linked to the manifestation of all three affective behavioral disorders, suggesting that they serve as points of integration of mechanisms underlying the convergence of depression, anxiety and fear.

Disruptions in the concentrations of GABA and glutamate are associated with deficits in affective behaviors (Calhoon and Tye, 2015; Jie et al., 2018). Activation of GABAergic neurons within the amygdala prevents the propagation of excitatory input to downstream regions and keeps anxiety responses in check (Calhoon and Tye, 2015). Either due to reduced GABA transmission or increased activity within the BLA following mild TBI, potentiation of glutamatergic activity may be associated with fear-related behaviors (Reger et al., 2012; McGuire et al., 2018). Anxiety-like behaviors following TBI in animals has been associated with decreased GAD expression in the BLA (Popovitz et al., 2019) or decreased evoked glutamate release and slower glutamate clearance within the CeA (Beitchman et al., 2020). Depression also manifests through imbalances in glutamate and GABA concentrations (Luscher et al., 2011; Luscher and Fuchs, 2015; Duman et al., 2019). For example, a postmortem study showed decreased levels of GABA expression in the BLA of patients with major depression disorder (Douillard-Guilloux et al., 2017). Thus, overall, reductions in GABA levels and excitotoxicity of glutamate, specifically within the amygdala, are major contributors to all three affective disorders, serving as a potential point of mechanistic convergence.

The expression of CRF is increased in the amygdala following brain injury (Narla et al., 2019; Tapp et al., 2019) and blockade of CRFR1 receptor 1 within the HPA axis attenuates post-traumatic stress and anxiety-like behaviors (Kosari-Nasab et al., 2019). The activity of CRF in extrahypothalamic regions contributes to depression, anxiety, and fear-related behaviors (Binder and Nemeroff, 2009; Sanford et al., 2017; Paretkar and Dimitrov, 2018). The CeA contains CRF-positive neurons (Rodaros et al., 2007), whereas the BLA contains numerous CRF receptor-positive projection neurons (Roozendaal et al., 2002). Increased CRF in the BLA can impair memory consolidation (Narla et al., 2019), whereas increased CRF in the nucleus accumbens leads to depressive behaviors likely by modulating extracellular acetylcholine (Chen et al., 2012); CRF receptor 1 antagonists exhibit antidepressant activity (Overstreet and Griebel, 2004). Neurons within the CeA that express CRF have been investigated for their role in perpetuating anxiety behaviors following chronic stress (Paretkar and Dimitrov, 2018; Hupalo et al., 2019) and promote fear learning by regulating acquisition recall (Sanford et al., 2017). Norepinephrine can promote GABA release from neurons thereby enhancing GABA-mediated inhibition of CRF neuronal activity (Levy and Tasker, 2012); norepinephrine is reduced following TBI suggesting that post-traumatic affective behaviors may be linked to CRF activity (McGuire et al., 2018). Together, these data suggest that hyperactivity of CRF neurons within the amygdala following injury may be a viable mechanistic underpinning of all three affective disorders.

Integration of Amygdala Structure and Function

In psychology, emotional processing describes the way in which an individual successfully responds to emotional stimuli or stressful events, and impairment in processing can lead to signs of depression, anxiety, and fear (Rachman, 1980) which have a high incidence of comorbidity in a subset of brain-injured patients (Jorge et al., 2004; Ellis et al., 2015; Mohammad Farris Iman Leong Bin Abdullah et al., 2018; Teymoori et al., 2020). The amygdala is well-known for its involvement in emotional processing based on observations of structural and functional alterations in patients that develop affective disorders such as depression and fear (Belujon and Grace, 2011; Douillard-Guilloux et al., 2017). Thus, a decrease in the number of somatostatin-labeled neurons within the BLA of the amygdala was observed in patients with major depression (Douillard-Guilloux et al., 2017). Additionally, in patients with generalized anxiety disorder, functional MRI during an emotional conflict task revealed greater activation in the amygdala (Etkin et al., 2010). Similarly, patients with PTSD exhibited an increase in amygdala activation detected using either positron emission tomography (Bremner et al., 2005) or blood oxygen level dependent functional MRI (Protopopescu et al., 2005), particularly when exposed to negative stimuli. The subregions of the amygdala, specifically the BLA and the CeA, may be the points of divergence in that impairment in each subregion is associated with a specific deficit. Thus, disruption in the BLA can result in the expression of depressive-like behaviors (Douillard-Guilloux et al., 2017), whereas impairment to the CeA can result in anxiety or fear-related behaviors (Calhoon and Tye, 2015). Because it is structurally and functionally impaired following mild TBI, the amygdala has been highlighted as critical to the development of post-traumatic deficits in affective behaviors. The true integration of these disorders lies in the connectivity between, and the neurochemical interactions within these two subregions of the amygdala. Therefore, impairment in the circuitry of BLA and CeA as well as disruptions in GABA or CRF concentrations post-injury have the potential to lead to comorbid expression of depression, anxiety, and fear-related behaviors. In these instances, the behavioral consequence exhibited would be one of a collective impairment in emotional processing.

Future Directions

Mild TBI is a public health concern that greatly impacts the lives of adolescents who suffer from sports-related concussion and young adults who experience mild blast TBI. A primary consequence of mild TBI is the development of long-term deficits in affective behaviors which have been reported in both humans and animals. It is important to note that the comorbidity of depression, anxiety, and fear-related behaviors are only observed in a subset of patients, and the appearance of these behaviors in preclinical models depends on the impact site and frequency of the repetitive injury. These behaviors have been largely understudied and there are few treatments in use currently that attenuate post-traumatic depression, anxiety, and fear/PTSD. Future clinical and preclinical studies need to examine the impairment in amygdala circuitry and neurotransmission following mild TBI. One of the major structural impairments following mild TBI is axonal injury and brain imaging must examine which projections to and from the different subregions of the amygdala are disrupted. In addition, alterations in the expression and activity of specific neurotransmitters must also be evaluated for the behavioral deficit being studied. Treatment paradigms therefore need to examine structural and functional alterations in the amygdala concomitantly with disruption in specific neurotransmitters facilitating an integrated approach, potentially ameliorating depression, anxiety, and fear-related behaviors together.

Author Contributions

TM, JB, and RR wrote and edited the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This study was supported, in part, by grants from the National Institutes of Health [R01 NS110898 (RR) and AA028218 (JB)] and Commonwealth Universal Research Enhancement from the Pennsylvania Department of Health [SAP 410-007-9710 (JB, RR) and SAP 410-007-7079 (RR)].

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References